In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification

Nuclear Medicine Communications

Volumn 22, Issue 5, 2001, Pages 499-504

  Edreira, M M ^a   Colombo, L L ^b   Perez, J H ^b   Sajaroff, E O ^b   de Castiglia, S G ^b  

^a DEPARTAMENTO DE FÍSICA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Murine mammary carcinoma; Radiopharmaceutical; Sentinel lymph node; Technetium labelled colloids

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; DEXTRAN 70; HUMAN SERUM ALBUMIN TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; FEMALE; FOOT PAD; ISOTOPE LABELING; METASTASIS; MOUSE; NONHUMAN; PARTICLE SIZE; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; ANTIMONY; DEXTRANS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; SERUM ALBUMIN; TECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION;

EID: 0035024394     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200105000-00006     Document Type: Article

References (16)

1. Keshtgar MRS, Ell PJ. Sentinel lymph node detection and imaging. Eur J Nucl Med 1999; 26: 57-67.
2. Glass E, Essner R, Guiliano E. Sentinel node localization in breast cancer. Sem Nucl Med 1999; XXIX: 57-68.
3. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
4. Morton DL, Wen D-R, Cochran A. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: an alternative to routine elective lymphadenectomy or ‘watch and wait’. Surg Oncol Clin North Am 1992; 1: 247-259.
5. Bomberdieri E, Crippa F, Maffioli L, Draisma A, Agresti R, Greco M. Nuclear medicine approaches for detection of axillary lymph node metastases. Q J Nucl Med 1998; 42: 54-65.
6. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999; 91: 368-373.
7. Paganelli G, De Cicco C, Cremonesi M, et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998; 42: 49-53.
8. De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39: 2080-2084.
9. Guiliano AE. Sentinel Lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J Surg Oncol 1996; 62: 75-77.
10. Guiliano AE, Dale PS, Turner RP, Morton DL, Evans SW, Krasne DL. Improved axillary staging of cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
11. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Onc 1997; 4: 104-110.
12. Strand S-E, Persson BRR. Quantitative lymphoscintigraphy I: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979; 20: 1038-46.
13. Bergqvist L, Strand S-E, Persson BRR. Particle sizing and biokinetics of intersticial lymphoscintigraphic agents. Sem Nucl Med 1983; 13: 9-19.
14. Hawkins LA, McAlister J. The use of 99mTc antimony sulphide colloid for liver scanning - its preparation and some clinical and experimental observations. Br J Radiol 1969; 42: 234-235.
15. Institute of Laboratory Animal Resources, National Research Council. Guide for the care and use of laboratory animals. Washington DC: National Academy Press, 1996.
16. Liotta LA, Stetler-Stevenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: Lippincott, 1993: 134-149.